Cargando…
121. Mucormycosis and COVID-19 in the United States: a Real-World Evidence Analysis of Risk Factors and Survival Among Patients with Mucormycosis, with and without COVID-19 Preceding the Infection
BACKGROUND: Mucormycosis has been associated with COVID-19 infections, notably in India, and known risk factors for mucormycosis such as diabetes mellitus have been studied in this context. This analysis aims to characterize patients in the US with mucormycosis, with and without COVID-19, by risk fa...
Autor principal: | Brzozowski, Kaylen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644853/ http://dx.doi.org/10.1093/ofid/ofab466.121 |
Ejemplares similares
-
COVID-19 and orbital mucormycosis
por: Sarkar, Sandip, et al.
Publicado: (2021) -
Mucormycosis in COVID-19 patients
por: Sundaram, Natarajan, et al.
Publicado: (2021) -
COVID-19 Associated Mucormycosis
por: Tazeem, Sana, et al.
Publicado: (2023) -
S2.1d Incidence of mixed fungal infections in post-COVID-19 outbreak of Mucormycosis
por: Mohapatra, Subhashree, et al.
Publicado: (2022) -
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
por: García-Carnero, Laura C., et al.
Publicado: (2022)